Insiders Aren’t Buying Pfizer Stock, and That Could Help
Pfizer stock hovers around the $26 level as insiders aren’t buying Pfizer stock. Analysts point to a patient, value-f...
Discover Weekly Automatic Buy Dividend Aristocrats Etf to set up a disciplined, recurring purchase schedule that smooths classic market timing.
14,755 articlesPfizer stock hovers around the $26 level as insiders aren’t buying Pfizer stock. Analysts point to a patient, value-f...
Three blue-chip names have slipped on the chart while trading below intrinsic value, offering income and upside for p...
As markets swing and rates climb, investors increasingly turn to high-yield REITs for reliable cash flow. This report...
Two oil giants enter 2026 with contrasting plays: Occidental Petroleum pares back, focusing on the Permian, while Exx...
Investors chase steady monthly cash without loading up on megacap tech. This piece explains how a Nasdaq-focused inco...
Unlock a practical, investor-friendly view of arbor realty (abr) earnings. Learn what drives ABR earnings, how to int...
With housing payments rising and rates lingering near multi-year highs, five categories of monthly dividend investmen...
Vodafone Group shares jumped about 13% after a dramatic stake reshuffle that makes Vega the largest shareholder. The ...
The global ship lease (gsl) market rides waves of charter rates and fleet utilization. This guide breaks down how gsl...
Cash flow from senior housing and warehouse REITs is holding steady even as refinancing costs rise. The payout outloo...
PepsiCo drives growth with international momentum while Procter & Gamble shines in beauty; both set the stage for a d...
When a large investor opens million position in an industrial REIT, it signals confidence in long-term cash flow and ...